| Title |
Janus kinase inhibitors for the treatment of COVID‐19
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2022
|
| DOI | 10.1002/14651858.cd015209 |
| Pubmed ID | |
| Authors |
Andre Kramer<sup>a</sup>, Carolin Prinz<sup>a</sup>, Falk Fichtner<sup>a</sup>, Anna-Lena Fischer, Volker Thieme, Felicitas Grundeis, Manuel Spagl, Christian Seeber, Vanessa Piechotta, Maria-Inti Metzendorf, Martin Golinski, Onnen Moerer, Caspar Stephani, Agata Mikolajewska, Stefan Kluge, Miriam Stegemann<sup>a</sup>, Sven Laudi<sup>a</sup>, Nicole Skoetz<sup>a</sup> |
X Demographics
The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 9% |
| United States | 3 | 6% |
| United Kingdom | 3 | 6% |
| Mexico | 3 | 6% |
| Japan | 3 | 6% |
| Hong Kong | 2 | 4% |
| Colombia | 2 | 4% |
| India | 1 | 2% |
| South Africa | 1 | 2% |
| Other | 7 | 13% |
| Unknown | 24 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 35 | 65% |
| Practitioners (doctors, other healthcare professionals) | 10 | 19% |
| Scientists | 8 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 123 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 11% |
| Student > Bachelor | 11 | 9% |
| Other | 9 | 7% |
| Student > Ph. D. Student | 8 | 7% |
| Student > Master | 7 | 6% |
| Other | 28 | 23% |
| Unknown | 47 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 30% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Agricultural and Biological Sciences | 4 | 3% |
| Engineering | 4 | 3% |
| Other | 20 | 16% |
| Unknown | 48 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#812,778
of 25,758,211 outputs
Outputs from Cochrane database of systematic reviews
#1,527
of 13,137 outputs
Outputs of similar age
#19,614
of 446,509 outputs
Outputs of similar age from Cochrane database of systematic reviews
#12
of 121 outputs
Altmetric has tracked 25,758,211 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,509 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.